Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


James C. Lanter

James C. Lanter, Raritan, NJ US

Patent application numberDescriptionPublished
20090215848Novel imidazolidIn-2-one derivatives as selective androgen receptor modulators (SARMS) - The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I08-27-2009
20090216023NOVEL INDOLE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.08-27-2009
20090258909Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.10-15-2009
20100298383NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.11-25-2010
20110021785NOVEL INDOLE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.01-27-2011
20110086883NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.04-14-2011

Patent applications by James C. Lanter, Raritan, NJ US

James C. Lanter, Audubon, PA US

Patent application numberDescriptionPublished
201002676884-AZETIDINYL-1-HETEROARYL-CYCLOHEXANE ANTAGONISTS OF CCR2 - The present invention comprises compounds of Formula (I).10-21-2010

James C. Lanter, Norristown, PA US

Patent application numberDescriptionPublished
200903124123,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE DERIVATIVES AS POTASSIUM CHANNEL OPENERS - The present invention is directed to novel 3,4-diamino-3-cyclobutene-1,2-dione derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.12-17-2009

James C. Lanter US

Patent application numberDescriptionPublished
20110166102NOVEL 2-SUBSTITUTED BENZIMIDAZOLES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.07-07-2011

James C. Lanter, Spring House, PA US

Patent application numberDescriptionPublished
20110306592CYCLOHEXYL-AZETIDINYL ANTAGONISTS OF CCR2 - The present invention comprises compounds of Formula (I).12-15-2011